表观遗传调控的Six3表达调节胶质母细胞瘤细胞增殖与侵袭并调控WNT通路成员活化水平
研究检测Six3在胶质瘤中的甲基化与表达,发现Six3在胶质瘤组织及多种胶质瘤细胞中低表达并与启动子甲基化相关。去甲基化处理或外源表达Six3可恢复Six3并抑制U251细胞G1/S转换、增殖、侵袭及Wnt1、p-GSK3-β、β-catenin、cyclin D1表达,而敲低SHG-44细胞Six3则作用相反。
要点
- Six3在胶质瘤组织和SHG-44、U251、SF126、U373-MG细胞中较正常组织低表达,与启动子甲基化相关。
- 去甲基化剂5-aza-2'-deoxycytidine或外源Six3恢复U251细胞Six3表达,抑制G1/S转换、增殖和侵袭。
- U251细胞恢复Six3后Wnt1、p-GSK3-β、β-catenin和cyclin D1表达下调,敲低SHG-44细胞Six3则作用相反。
核心结论
- Six3在胶质瘤中因启动子高甲基化而沉默或缺失,Six3下调促进胶质瘤增殖和侵袭,该过程涉及Wnt/β-catenin通路活化。
- Six3在人类胶质瘤发生和进展中发挥抑制因子作用,可能作为诊断和治疗靶点。
研究设计与样本
- 研究比较人胶质瘤组织与人胶质瘤SHG-44、U251、SF126和U373-MG细胞及正常组织中Six3的表达与甲基化。
- 在U251细胞中使用去甲基化剂5-aza-2'-deoxycytidine或外源表达Six3,在SHG-44细胞中敲低Six3。
主要发现
- 与正常组织相比,Six3在人胶质瘤组织及SHG-44、U251、SF126和U373-MG细胞中下调,且下调与启动子甲基化相关。
- U251细胞缺乏内源性Six3,经5-aza-2'-deoxycytidine或外源Six3处理后恢复Six3产生,并抑制细胞周期G1/S转换、增殖和侵袭。
- U251细胞恢复Six3后Wnt1、p-GSK3-β、β-catenin和cyclin D1表达下调。
- 在基线Six3相对较高的SHG-44细胞中敲低Six3产生相反作用。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Glioma is the most common primary brain tumor in adults. Six3 is a human homologue of the highly conserved sine oculis gene family and essential transcription regulatory factor in process of eye and fetal forebrain development. However, little is known about the role of Six3 in human tumorigenesis. The aim of this study is to investigate the methylation/expression of Six3 and reveal its function and action mechanism in glioma. Our results showed that Six3 was down-regulated in human glioma tissues and human glioma SHG-44, U251, SF126 and U373-MG cells compared with the normal tissues. And the down-regulation of Six3 was associated with the methylation of its promoter. Glioma U251 cells lacked endogenous Six3. Treatment with demethylating agent (5-aza-2'-deoxycytidine) or exogenous expression of Six3 restored Six3 production and resulted in suppression of cell cycle G1/S transition, proliferation and invasion and down-regulation of the expression of Wnt1, p-GSK3-β, β-catenin and cyclin D1 in glioma U251 cells. However, knockdown of Six3 in SHG-44 cells, which have relative higher baseline level of Six3, resulted in an opposite action. These results demonstrate that Six3 silence or loss in glioma is induced by its promoter hypermethylation and Six3 down-regulation contributes to proliferation and invasion of glioma. And this process is involved in activation of Wnt/β-catenin pathway. Six3 play a suppressor role in the initiation and progression of human glioma and potentially serve as a target for the diagnosis and treatment of human glioma.
引用
- Zhang B, Shen C, Ge F, et al. Epigenetically controlled Six3 expression regulates glioblastoma cell proliferation and invasion alongside modulating the activation levels of WNT pathway members. J Neurooncol. 2017. PMID: 28643150. doi:10.1007/s11060-017-2476-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。